1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South and Central America Allergy Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South and Central America Allergy Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South and Central America Allergy Treatment Market Regional Analysis
6.2 South and Central America Allergy Treatment Market Revenue 2018-2028 (US$ Million)
6.3 South and Central America Allergy Treatment Market Forecast Analysis
7. South and Central America Allergy Treatment Market Analysis – by Allergy Type
7.1 Eye Allergy
- 7.1.1 Overview
- 7.1.2 Eye Allergy: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.2 Rhinitis
- 7.2.1 Overview
- 7.2.2 Rhinitis: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.3 Asthma
- 7.3.1 Overview
- 7.3.2 Asthma: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.4 Skin Allergy
- 7.4.1 Overview
- 7.4.2 Skin Allergy: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.5 Food Allergies
- 7.5.1 Overview
- 7.5.2 Food Allergies: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.6 Other Allergies
- 7.6.1 Overview
- 7.6.2 Other Allergies: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
8. South and Central America Allergy Treatment Market Analysis – by Treatment
8.1 Anti-Allergy Drugs
- 8.1.1 Overview
- 8.1.2 Anti-Allergy Drugs: South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
8.2 Immunotherapy
- 8.2.1 Overview
- 8.2.2 Immunotherapy : South and Central America Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
9. South and Central America Allergy Treatment Market – South and Central America Analysis
9.1 Overview
9.2 South and Central America
- 9.2.1 South and Central America Allergy Treatment Market Breakdown, by Key
Country, 2021 and 2028 (%)
- 9.2.1.1 South and Central America Allergy Treatment Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 Brazil:
South and Central America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 Brazil: South and Central America Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.1.2 Brazil: South and Central America Allergy Treatment Market Breakdown, by Treatment
- 9.2.1.2 Argentina:
South and Central America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Argentina: South and Central America Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.2.2 Argentina: South and Central America Allergy Treatment Market Breakdown, by Treatment
- 9.2.1.3 Rest of South and Central America :
South and Central America Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Rest of South and Central America : South and Central America Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.3.2 Rest of South and Central America : South and Central America Allergy Treatment Market Breakdown, by Treatment
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Johnson and Johnson Services, Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sanofi
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AbbVie's Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ALK-Abelló A/S
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Allergy Therapeutics
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Stallergenes Greer
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 GlaxoSmithKline PLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations